-
Evaluation of Adverse Drug Events in Patients on Anti-Retroviral Therapy Regimen at Omdurman Voluntary Counselling and Testing and Anti-Retroviral Therapy Center in Sudan – A Cross-Sectional Study
20 Apr 2024 07:43 GMT
… combined medications. The relationship between each medication and … laboratory or clinical trials; however, patients … (tenofovir + lamivudine + efavirenz) regimen, which reflects doctors adherence … et al. Antiretroviral drugs for treatment and prevention of HIV …
-
Drug Use Evaluation of Tenofovir/Lamivudine/Dolutegravir (TLD) Fixed-Dose Combination for Initiation and Transition Among HIV-Infected Individuals Attending Lumame Primary Hospital, North West Ethiopia
18 Apr 2024 07:34 GMT
… for dangerous side effects, drug interactions, and drug resistance.12 On the … HIV care and treatment services.5 The use of Tenofovir/Lamivudine … safe and appropriate use of pharmaceuticals, medical procedures, and new research ideas …
-
How did Germany run low on potentially life-saving HIV medication?
13 Apr 2024 07:00 GMT
… was running low when his doctor advised him to space … to reduce the number of pills I take, four rather … uncertainty about prescription practices, drug risks and compliance with generic … to ship Emtricitabine and Tenofovir-based medicines to Europe.
In Germany …
-
Opioid Use Disorder Research Roundup: April 19, 2024
19 Apr 2024 21:16 GMT
… PIU and comorbidities in OUD treatment,” the investigators concluded. “Interventions … providing individuals who inject drugs with medication for OUD using buprenorphine … exposure prophylaxis (PrEP) with tenofovir disoproxil fumarate/emtricitabine through …
-
Week in review: BLA accepted for meningococcal vaccine, single-tablet HIV regimen data
19 Apr 2024 13:40 GMT
… you may have missed.
1.) FDA accepts BLA for meningococcal ABCWY … article.
2.) Bictegravir, emtricitabine, and tenofovir alafenamide efficacy, safety in children … antibody was approved by the FDA on July 17, 2023 and …
-
Regulatory tracker: J&J, Legend's Carvykti wins second-line myeloma nod in Europe
03 Jan 2024 17:45 GMT
… the tenofovir product … trials.
After a July rejection, Citius Pharmaceuticals is once again seeking FDA … drug met its endpoints of objective response rate and duration of response, the biotech … medicine, plus diet and other LDL-C therapies, for the treatment …
-
Switching from TAF to TDF leads to weight loss
23 Apr 2024 06:32 GMT
… to the older formulation of tenofovir disoproxil (TDF) resulted in … from TAF-containing treatment to a two-drug combination of dolutegravir … or efavirenz. But randomised trials which have looked at … smoking and use of other medications known to affect weight). …
-
The Best Defensive Stocks to Buy
23 Apr 2024 00:14 GMT
… market leader in both biotech and diagnostics, this … (more than 80% of pharmaceutical sales) provides some buffer … other vaccines, cancer treatments, and cardiovascular drugs.
Pfizer’s foundation …
Gilead’s tenofovir, or TDF, molecule—in Viread, Truvada, and …
-
Reasons, Efficacy and Safety of Switching to Dolutegravir-Based Regimens Among Virologically Suppressed PLWH: A Retrospective Cohort Study of 96 Weeks
22 Apr 2024 17:30 GMT
… or substitution drugs. One such pharmaceutical option is … the electrical clinical medical record system and … treatment options (n=4), pill burden (n=2), clinical trial (n=2) and drug-drug … Switching from tenofovir alafenamide to tenofovir disoproxil fumarate …
-
Practical Considerations of T-Cell Engagers in the Management of Relapsed/Refractory Multiple Myeloma
21 Apr 2024 16:44 GMT
… outcomes within this evolving treatment landscape.
Introduction
Multiple … when the medication order is placed and drug administration.
… the MagnetisMM-3 trial is FDA approved for elranatamab … for prophylaxis with entecavir, tenofovir, or lamivudine, whereas …